Tirzepatide, an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and obesity, works through incretin-based glucose regulation and appetite suppression
doi:10.1016/j.ynstr.2023.100543
5.6.4 Endpoint selection and standardization Across the 12 RCTs, seven different primary endpoints were used (VAS, TCSS, NDS, VPT, NSS, SNAP, SNCV), and only two trials adopted composite scores recommended by the Toronto Consensus on Diabetic Neuropathy (Pop-Busui et al., 2017)
Several common inducers and inhibitors related to ferroptosis are shown in Table 2
GHK-Cu binds to copper ions and delivers them to skin cells, activating pathways involved in cell renewal, wound repair, and anti-inflammatory response
174 XRCC1, a protein of 69.5 kilodaltons and consists of 633 amino acids (including six cysteines), aids in recruiting proteins for base excision repair by interacting with PARP1, ligase III, APE1, and pol